Find clinical trials for Heart Disease in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Washington, DC, USA:
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
Baltimore, Maryland, United States and 60 other locations
In this randomized clinical trial, the researchers are investigating whether a multi-component virtual/hybrid cardiac rehabilitation program...
Baltimore, Maryland, United States
Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coron ...
Baltimore, Maryland, United States
To collect information about treatment for severe aortic stenosis (AS), which affects the aortic valve in the heart. Aortic stenosis is a na...
Washington, District of Columbia, United States and 12 other locations
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Washington, District of Columbia, United States and 60 other locations
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Washington, District of Columbia, United States and 10 other locations
The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population)...
Baltimore, Maryland, United States
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe ...
Phase 2
Baltimore, Maryland, United States and 32 other locations
native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open ...
Washington, District of Columbia, United States and 8 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Washington, District of Columbia, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal